CMC Microsystems
Hurry, get your tickets today!
Details Here

Arben Merkoçi

ICREA Professor

ICREA, Institut Català de Nanociencia i Nanotecnologia (ICN2), BIST Barcelona, Spain

Arben Merkoçi is ICREA Research Professor and leader of the ICN2 Nanobioelectronics and Biosensors Group. He obtained his PhD at the University of Tirana (Albania) and since 1992 has carried out research as a postdoctoral fellow and research professor in Hungary, Greece, Italy, Spain and USA. His research is focused on the integration of biological molecules and other species with micro- and nanostructures of interest in the design of novel (bio)sensors. Prof. Merkoçi has published 332 articles (H-index: Google Scholar 85; WOS 74) and supervised 35 PhD theses. He has served as scientific evaluator / member of panels of experts of various international institutions and has been invited to give plenary lectures etc. on more than 200 occasions in various countries. Prof. Merkoçi is the co-founder of two spin-off companies: GraphenicaLab, devoted to graphene patterning, and PaperDrop, dedicated to clinical diagnostics.

Sessions Arben Merkoçi is a part of

Wednesday, June 8, 2022

What will it take to make personalized and precision medicine mainstream within 15 years?

3:50 pm to 5:05 pm
in Salon 9

Talk Description

Nanobiosensors as cost effective diagnostics devices for point of care applications

Some examples of nanobiosensors based on either plastic of paper platforms will be presented. These devices should be REASSURED: Real-time connectivity, Ease of specimen collection, Affordable, Sensitive, Specific, User-friendly, Rapid, Robust, Equipment-free, Delivered to those who need it. How to design simple plastic/paper-based biosensor architectures through printing or stamping? How to tune their analytical performance upon demand? How one can use nanomaterials and what is the benefit? Which are the perspectives to link these simple platforms with mobile communication? I will try to give responses to these questions through various interesting applications related to protein, DNA and even bacteria and viruses with extreme interest for clinical emergency applications. The developed platforms and related technologies are related to ubiquitous methods that would be quite important for democratising diagnosis and improving the healthcare coverage all over the world.

© 2024 NanoCanada. All rights reserved.

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram